A Phase II clinical trial in patients with symptomatic glucocorticoid naive asthma has been conducted in 2001/2002.
A clinical test was performed on individuals experiencing symptoms of asthma that had not yet received corticosteroid treatment, which occurred between 2001 and 2002.